ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,172, issued on Sept. 9, was assigned to UNION therapeutics A/S (Hellerup, Denmark).

"Dosage regimen" was invented by Morten Otto Alexander Sommer (Hellerup, Denmark), Jakob Felding (Hellerup, Denmark), Kim Domela Kjoller (Hellerup, Denmark), Mads Jellingso (Hellerup, Denmark), Morten Lind Jensen (Hellerup, Denmark) and Eckhard Niemeier (Hellerup, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is orismilast for use in the treatment a disease or disorder ameliorated by inhibiting PDE4 in a subject, wherein the orismilast is administered to the subject according to a specific dosage regimen. Also provided is orismilast for use ...